MENU
INZY
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Inozyme Pharma (INZY) Earnings Date & Reports

Inozyme Pharma Inc is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting bone health and blood vessel function... Show more

A.I. Advisor
published Earnings

INZY is expected to report earnings to fall 2.78% to -39 cents per share on May 13

Inozyme Pharma INZY Stock Earnings Reports
Q1'25
Est.
$-0.40
Q4'24
Missed
by $0.01
Q3'24
Beat
by $0.05
Q2'24
Missed
by $0.04
Q1'24
Missed
by $0.03
The last earnings report on March 10 showed earnings per share of -40 cents, missing the estimate of -40 cents. With 194.15K shares outstanding, the current market capitalization sits at 59.51M.
View a ticker or compare two or three
INZY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a company, which engages in the research and development of pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
321 Summer Street
Phone
+1 857 330-4340
Employees
59
Web
https://www.inozyme.com